Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 8—August 2005

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use

Conan MacDougall*, Spencer E. Harpe*, J. Patrick Powell*, Christopher K. Johnson†, Michael B. Edmond*, and Ron E. Polk*Comments to Author 
Author affiliations: *Virginia Commonwealth University, Richmond, Virginia, USA; †Idaho State University, Boise, Idaho, USA

Main Article

Table 1

Demographic characteristics of study hospitals, year 2002*

Characteristic Mean ± SD Median (range)
No. admissions 19,122 ± 12,208 14,720 (5,206–40,676)
No. patient-days 96,488 ± 64,719 76,408 (19,244–219,634)
Case mix index 1.51 ± 0.245 1.52 (1.13–2.01)
Length of hospital stay, d 5 ± 0.67 5 (3.6–6.6)
No. staffed beds 358 ± 203 310 (105–778)
No. intensive care unit beds 22 ± 16 18 (3–80)
No. surgical procedures/1,000 admissions 346 ± 184 281 (163–779)

*SD, standard deviation.

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.